Literature DB >> 12379905

Role of p38 and p44/42 mitogen-activated protein kinases in microglia.

Milla Koistinaho1, Jari Koistinaho1,2.   

Abstract

Although microglial cells are thought to play a beneficial role in the regeneration and plasticity of the central nervous system (CNS), recent studies have indicated that at least some molecules released by microglia may be harmful in acute brain insults and neurodegenerative diseases. Therefore, the pathways mediating the synthesis and release of these neurotoxic compounds are of importance. p38 and p44/42 families of mitogen-activated protein kinases (MAPKs) in microglia respond strongly to various extracellular stimuli, such as ATP, thrombin, and beta-amyloid, a peptide thought to be responsible for the neuropathology in Alzheimer's disease. In this review we describe in vivo evidence implicating that p38 and p44/42 MAPKs may play a critical role in harmful microglial activation in acute brain injury, such as stroke, and in more chronic neurodegenerative diseases, such as Alzheimer's disease. We also clarify the extracellular signals responsible for activation of p38 and p44/42 MAPK in microglia and review the responses so far reported to be mediated by these kinases. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379905     DOI: 10.1002/glia.10151

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   8.073


  76 in total

Review 1.  Atypical antiinflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine-phosphatidylserine receptor interaction.

Authors:  Roberta De Simone; Maria Antonietta Ajmone-Cat; Luisa Minghetti
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

Review 2.  Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors.

Authors:  Kyoungho Suk; Jiyeon Ock
Journal:  Inflammopharmacology       Date:  2011-12-22       Impact factor: 4.473

3.  Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells.

Authors:  Patrick L Crittenden; Nikolay M Filipov
Journal:  J Appl Toxicol       Date:  2011-01       Impact factor: 3.446

4.  The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.

Authors:  Adam D Bachstetter; Linda J Van Eldik
Journal:  Aging Dis       Date:  2010-09-24       Impact factor: 6.745

Review 5.  Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.

Authors:  Kathryn E Medders; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-01       Impact factor: 4.147

6.  Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.

Authors:  Zhi-Ye Zhuang; Yasuhiko Kawasaki; Ping-Heng Tan; Yeong-Ray Wen; Jing Huang; Ru-Rong Ji
Journal:  Brain Behav Immun       Date:  2006-12-15       Impact factor: 7.217

7.  2-Cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride inhibits microglial activation by suppression of nuclear factor-kappa B and mitogen-activated protein kinase signaling.

Authors:  Eun-A Kim; Jiyoung Choi; A Reum Han; Chang Hun Cho; Soo Young Choi; Jee-Yin Ahn; Sung-Woo Cho
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-22       Impact factor: 4.147

8.  Toll-like receptor 2 mediates peripheral nerve injury-induced NADPH oxidase 2 expression in spinal cord microglia.

Authors:  Hyoungsub Lim; Donghoon Kim; Sung Joong Lee
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

9.  Neural inflammation and the microglial response in diabetic retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Ocul Biol Dis Infor       Date:  2012-04-24

10.  Microglia induce neurotoxicity via intraneuronal Zn(2+) release and a K(+) current surge.

Authors:  Megan E Knoch; Karen A Hartnett; Hirokazu Hara; Karl Kandler; Elias Aizenman
Journal:  Glia       Date:  2008-01-01       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.